Resumo:
MajesTEC3
Estudo de Fase 3, randomizado, para comparar Teclistamabe em combinação ao Daratumumabe SC (Tec-Dara) versus Daratumumabe SC, Pomalidomida e Dexametasona (DPd) ou Daratumumabe SC, Bortezomibe e Dexametasona (DVd) em participantes da pesquisa com mieloma múltiplo recidivado ou refratário
Patrocinador:
Janssen
Resumo:
Brasília / DF e Salvador / BA
Instituição: IDOR DF e IDOR Salvador
Informações: 11 94257-9076 (WhatsApp) / 11 2109-8804
E-mail: nucleodecaptacao@idor.org
Cookie | Duração | Descrição |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |